Theravance Biopharma, Inc. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Theravance Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Theravance Biopharma, Inc. for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 29.09 | 4,566 | 132,825 | 163,563 | 168.1 K to 163.6 K (-2.72 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 29.09 | 13,005 | 378,315 | 881,372 | 894.4 K to 881.4 K (-1.45 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Payment of Exercise | F | 29.09 | 8,770 | 255,119 | 101,230 | 110 K to 101.2 K (-7.97 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Payment of Exercise | F | 29.09 | 5,587 | 162,526 | 130,661 | 136.2 K to 130.7 K (-4.10 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Payment of Exercise | F | 29.09 | 4,252 | 123,691 | 152,054 | 156.3 K to 152.1 K (-2.72 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | PASQUALONE FRANK | SVP, Chief Comm Ops ... | Payment of Exercise | F | 29.09 | 4,741 | 137,916 | 211,619 | 216.4 K to 211.6 K (-2.19 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | HEGDE SHARATHCHANDRA S | SVP, Research | Payment of Exercise | F | 29.09 | 4,349 | 126,512 | 159,611 | 164 K to 159.6 K (-2.65 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 29.09 | 8,293 | 241,243 | 142,203 | 150.5 K to 142.2 K (-5.51 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | GALA RENEE D | SVP, Chief Financia ... | Payment of Exercise | F | 29.09 | 5,387 | 156,708 | 211,407 | 216.8 K to 211.4 K (-2.48 %) |
| Feb 15 2018 | TBPH | Theravance Biophar ... | Smaldone Alsup Laurie | Director | Option Exercise | A | 28.14 | 1,500 | 42,210 | 1,500 | |
| Feb 15 2018 | TBPH | Theravance Biophar ... | Smaldone Alsup Laurie | Director | Option Exercise | A | 28.14 | 12,000 | 337,680 | 12,000 | |
| Feb 15 2018 | TBPH | Theravance Biophar ... | Smaldone Alsup Laurie | Director | Grant | A | 0.00 | 1,776 | 0 | 1,776 | 0 to 1.8 K |
| Feb 14 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 9,000 | 0 | 168,129 | 159.1 K to 168.1 K (+5.66 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 28,000 | 0 | 894,377 | 866.4 K to 894.4 K (+3.23 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 25,000 | 0 | 110,000 | 85 K to 110 K (+29.41 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 65,000 | 0 | 85,000 | 20 K to 85 K (+325.00 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | Shafer Bradford J | EVP, Gen. Counsel, ... | Grant | A | 0.00 | 9,000 | 0 | 136,248 | 127.2 K to 136.2 K (+7.07 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | PITZER KENNETH R | SVP, Prod Strat & C ... | Grant | A | 0.00 | 9,000 | 0 | 156,306 | 147.3 K to 156.3 K (+6.11 %) |